Autoantibody Screening of Siblings in the Teplizumab Era: From a Single Measurement to Treatable Stages of Type 1 Diabetes

Authors

Institutions

Publication Details

Journal
Diabetes Obesity and Metabolism
Published
2026-10-06
DOI
https://doi.org/10.1111/dom.71425
Primary Topic
Diabetes and associated disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Autoantibody Screening of Siblings in the Teplizumab Era: From a Single Measurement to Treatable Stages of Type 1 Diabetes

Yueming Luo
Diabetes Obesity and Metabolism
Diabetes and associated disorders
article

Autoantibody Screening of Siblings in the Teplizumab Era: From a Single Measurement to Treatable Stages of Type 1 Diabetes

Yueming Luo
article en

Abstract

No abstract available for this paper.
Diabetes Obesity and Metabolism
Shenzhen Pingle Orthopedic Hospital (CN)
Openalex Percentile: Top 13%
Diabetes and associated disorders
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Autoantibody Screening of Siblings in the Teplizumab Era: From a Single Measurement to Treatable Stages of Type 1 Diabetes — Yueming Luo · Diabetes Obesity and Metabolism (2026) | TGRS Research Map | TGRS